Summary: UnitedHealth Group Inc.

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • According to MSCI, the company's ESG score for its industry is good.

Highlights: UnitedHealth Group Inc.

  • With regards to fundamentals, the enterprise value to sales ratio is at 0.72 for the current period. Therefore, the company is undervalued.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses: UnitedHealth Group Inc.

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings Chart: UnitedHealth Group Inc.

Source: Surperformance

ESG chart: UnitedHealth Group Inc.

Source: MSCI

Fundamentals (Composite) Global Valuation (Composite) Financial estimates revisions (Composite) Capi.($)
279B
83.35B
78.96B
28.66B
16.22B
12.52B
- 2.71B
2.08B
- 1.55B
Average 56.13B
Weighted average by Cap.
See all sector ratings
Investor (Composite)
Trader (Composite)
ESG MSCI
BBB

Financials

Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)

Valuation

P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield

Revisions

Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)

Consensus

Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)

Business Predictability

Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence

ESG

Environment
Social
Governance
Controversy
Ethical controversies
Human rights controversies
Tax subsidies controversies
Sharia compliant

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. UNH Stock
  4. Ratings UnitedHealth Group Inc.